Study of ISM5939 in Patients With Advanced and/or Metastatic Solid Tumors
Clinical trial NCT06724042 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06724042
- Sponsor
- InSilico Medicine Hong Kong Limited
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-12-30
- Primary completion
- 2029-12-30
- Enrollment
- 159
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.